Menu
From our family at the " Jewish News Today " to your family Happy Chanukah and best wishes

From our family at the " Jewis…

During Chanukah lets all ...

World Jewish Congress urges UN Security Council to take collective action against Hamas

World Jewish Congress urges UN Secu…

NEW YORK – The World Jewi...

3rd Diplomatic Race to celebrate Israel's special needs community

3rd Diplomatic Race to celebrate Is…

Ahead of International Da...

Deadly Shooting at Pittsburgh Synagogue

Deadly Shooting at Pittsburgh Synag…

According to police and m...

PM Netanyahu's remarks at the start of the weekly cabinet meeting

PM Netanyahu's remarks at the start…

PM Netanyahu: "Israel sta...

11 Dead, 6 Injured in Pittsburgh Synagogue Shooting

11 Dead, 6 Injured in Pittsburgh Sy…

The gunman who killed 11 ...

World Jewish Congress expresses concern at explosion targeting Jewish community leader in Kazan, Tatarstan

World Jewish Congress expresses con…

NEW YORK - The World Jewi...

PM Netanyahu addresses the Christian Media Summit

PM Netanyahu addresses the Christia…

Iran wants to base itself...

PM Netanyahu visits the Ein Keshatot archaeological site on the Golan Heights

PM Netanyahu visits the Ein Keshato…

We will continue to act w...

PM Netanyahu and Chancellor Merkel hold working meeting

PM Netanyahu and Chancellor Merkel …

​We are seizing the futur...

Prev Next
A+ A A-
Booking.com

Teva Announces: President and CEO. Dr. Jeremy Levin steps down as President and CEO, Eyal Desheh, Teva's Group EVP & Chief Financial Officer, named interim President and CEO Featured

JERUSALEM, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its Board of Directors has agreed with Dr. Jeremy Levin that he will step down as President and Chief Executive Officer. The Board has named Eyal Desheh, Teva's Executive Vice President and Chief Financial Officer, to fill the role of President and Chief Executive Officer on an interim basis, effective immediately, and it has formed a committee that will promptly begin to search for a permanent successor. 

Dr. Phillip Frost, Chairman of the Board, stated “On behalf of the entire Board of Directors, I would like to thank Dr. Jeremy Levin for his meaningful contribution to Teva during the last two years. The Board and management team are fully committed to the implementation of Teva's strategy, including the development of new compounds, making strategic acquisitions, forming joint ventures and the planned acceleration of the Company’s cost reduction program.”

“Since I joined Teva, we have made tremendous progress in setting a new course for the Company,” said Dr. Jeremy Levin. "I wish the Company and its people, who I respect greatly, every success. I look forward to pursuing new opportunities where I can continue to apply my experience and contribute to the evolution of the global pharmaceutical industry.”

"I have full confidence in the ability of Teva's management and employees to achieve our goals and execute the strategy laid out for the Company,” said Eyal Desheh, who has served at Teva for over 12 years, including the last five as Chief Financial Officer. “My colleagues in Teva's management and I will continue to drive execution and results in full collaboration with our Board of Directors, for the benefit of our patients, shareholders, customers and employees."

As previously scheduled, Teva will report its third quarter 2013 financial results on October 31, 2013.
Last modified onMonday, 09 January 2017 15:10

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top

Sections

Jewish Traditions

About Us

Community

Cooperations

Follow Us